Experience using intravenous posaconazole in paediatric and young adult oncology patients

BACKGROUND: Posaconazole exhibits broad-spectrum antifungal activity. An IV formulation became available in 2014. Few studies describing the use of this formulation exist in patients under the age of 18 years. This study describes our experience using IV posaconazole in paediatric and young adult ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Antimicrob Chemother
Egile Nagusiak: Lambrix, Arathi A, Swanson, Hope D, Pauley, Jennifer L, Bragg, Allison W, Carias, Delia C, Bourque, Melissa S, Zhou, Yinmei, Cheng, Cheng, Greene, William L, Maron, Gabriela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662186/
https://ncbi.nlm.nih.gov/pubmed/32929484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa377
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak